Skip to main content

Table 4 Prevalence and diagnostic performance observed at Guatemala Site 2

From: Independent clinic-based evaluation of point-of-care testing for the screening of Chlamydia trachomatis, Neisseria gonorrhoea and Trichomonas vaginalis in women-at-risk in Australia, Guatemala, Morocco, and South Africa

Parameter

Chlamydia

Gonorrhoea

Trichomoniasis

Prevalence

7.6%

1.0%

8.0%

Sensitivity (CI)

84.6% (71.9–93.1)

100% (59.0-100)

60.0% (45.2–73.6)

Specificity (CI)

99.0% (97.9–99.7)

100% (99.5–100)

100% (99.4–100)

Change to pooled estimates:

   

 Sensitivity (CI)

83.6% (72.8–90.6)

90.9% (85.7–94.4)

64.0% (58.9–68.9)

 Specificity (CI)

98.3% (96.9–99.1)

99.6% (98.1–99.9)

99.6% (97.5–100)

 Likelihood Ratio + (CI)

48.7 (27.8–85.5)

240.3 (47.6-1214.8)

176.6 (25.5–1224.0)

 Likelihood Ratio - (CI)

0.17 (0.10–0.29)

0.09 (0.06–0.15)

0.36 (0.31–0.42)